We report phase II trial results of the use of oral anagrelide hydrochloride for treating 38 patients with hydroxyurea (HU)-resistant thrombocytosis accompanying chronic myeloid leukemia (CML).
Discover comprehensive details about Anagrelide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
Review the side-effects of Anagrelide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
One lot of Anagrelide Capsules got recalled by Torrent Pharmaceuticals after the capsules didn’t dissolve properly during routine testing, according to Wednesday’s FDA-posted recall notice. Anagrelide ...
Primary endpoint results of the phase 3b ASC4START trial of asciminib (ASC) vs nilotinib (NIL) in newly diagnosed chronic phase chronic myeloid leukemia (CML-CP): Time to treatment discontinuation due ...
A total of 809 patients with essential thrombocythemia who were at high risk for vascular events received low-dose aspirin plus either anagrelide or hydroxyurea. The composite primary end point was ...
Because of these different pharmacological profiles, comparison between ANA and HC with regard to their selectivity and mode of action is important to help in the evaluation of their relative risk to ...
The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study. This is an ASCO Meeting Abstract from the 2014 ASCO Annual ...
Cancer therapeutics firm Galena Biopharma acquired Mills Pharmaceuticals and in the process added Mills’ GALE-401 (anagrelide CR), a controlled-release formulation of anagrelide, to its pipeline. The ...
Torrent Pharmaceuticals is voluntarily recalling one lot of Anagrelide capsules, USP, to the consumer level due to dissolution test failure detected during routine quality testing, according to the US ...
Ill-dissolving capsules can hamper drugs’ effectiveness or render them useless, which is especially concerning when they’re used to treat seriously sick blood disorder patients. Teva Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results